Search results
AbbVie Completes Acquisition of Landos Biopharma
The Longview News-Journal· 2 days agoWith the completion of the acquisition, Landos is now part of AbbVie. Landos' lead investigational asset is NX-13, a first-in-class, oral NLRX1 agonist (a member of the NOD-like receptor family ...
SuperCom Announces New Contract Win in North California
FOX 5 San Diego· 2 days agoSuperCom (NASDAQ: SPCB), a global provider of secure solutions for the e-Government, IoT, and Cybersecurity sectors, announced today that its fully-owned subsidiary, Leaders in Community Alternatives ...
TiNY Report for May 23, 2024 | JD Supra
JD Supra· 2 days agoIt would be perfect weather to stand outside of Key Bank Center and watch the Sabres play in the Eastern Conference Finals on a portable Jumbotron. Shouldn’t it be “The Sabres was victorious ...
Swiss Re Foundation aims to boost health and environmental innovations through Shine Southeast Asia
The Norman Transcript· 4 days agoShine, Swiss Re Foundation's flagship social entrepreneurship programme, invites participation from social entrepreneurs from Indonesia, Malaysia, Singapore, and Thailand. The programme provides ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 2 days agoAbbVie Completes Acquisition of Landos Biopharma PR Newswire NORTH CHICAGO, Ill., May 23, 2024 - Adds first-in-class investigational asset, NX-13, to AbbVie's pipeline with the potential to offer a novel approach to the treatment of ulcerative
Vail Mountain School’s favorite ‘Señor’ retires after 39 years
Vail Daily· 6 days agoFor 39 years, Steve Gordon — or Señor as he’s commonly known — has been a fixture at Vail Mountain...
